CARB-X announced today that it’s awarding $1.2 million to a research team at Harvard University to develop enhanced antibiotics for multidrug-resistant bacteria.

Scientists at Duke University report they have developed a synthetic antibiotic that could be effective against drug-resistant superbugs and bacteria such as Salmonella, Pseudomonas, and E. coli.

BRD is often framed as stress, viruses and bacteria. Managing inflammation tied to endotoxin helps explain why some cattle recover faster than others ...

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E. coli (STEC), the notorious bug associated with severe food poisoning.

Gram-negative bacteria deploy a range of protein toxins as mediators of inter-bacterial competition and pathogenicity. Among these, colicins comprise a class of ribosomally synthesised bacteriocins ...

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E. coli (STEC), the notorious bug associated with severe food poisoning.

A team led by Paul Hergenrother at the University of Illinois Urbana-Champaign has discovered a new antibiotic that exclusively targets gram-negative bacteria and avoids wiping out the ecosystem of ...

Please provide your email address to receive an email when new articles are posted on . Gram-negative bacteria comprise most of the CDC and WHO’s lists of critical and urgent antibiotic-resistant ...

A polyp lesion with colibactin-producing E. coli (pks+) is shown in panels A–C. (A) HE staining of the polyp lesion, which shows high-grade tubular adenoma. (B) High magnification of A. (C) A few ...